Press

25. Nov. 2024

Aphaia Pharma to Participate in a Panel Discussion at the 1st Annual Obesity & Metabolic Innovation Forum

ZUG, Switzerland, SAN JUAN, Puerto Rico and TORONTO, November 25, 2024 – Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine…

Read More

Press

25. Nov. 2024

43rd Annual J. P. Morgan Health Conference in San Francisco

From 10 - 16 January, Günter Jucho, CFO of Aphaia Pharma AG, will be attending the 43rd annual J. P. Morgan Healthcare Conference in San…

Read More

26. Jun. 2024

Strategic planning workshop – Qanatpharma AG

#FeatureFriday Members of Qanatpharma AG's Swiss, German and Canadian team had a great strategic planning workshop this week in beautiful Lucerne to discuss our forthcoming…

Read More

16. Apr. 2024

Swiss Biotech Day

Der diesjährige Swiss Biotech Day wird mit einem Team der schweizerischen Qanatpharma AG besucht: Prof. Steffen Sebastian Bolz (Unternehmensgründer),  Dr. Philipp Trepte (Director Qanatpharma Germany),…

Read More

11. Jul. 2023

FOCUS-Biotech firms target weight-loss drugs without Wegovy’s side-effects

LONDON, July 7 (Reuters) – Weight-loss drug Wegovy helped Rebecca Vogt achieve a major goal - shedding the weight she had not managed to drop…

Read More